Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields

<p>Abstract</p> <p>Glioblastoma multiforme (GBM) is the most common and malignant primary intracranial tumor, and has a median survival of only 10 to 14 months with only 3 to 5% of patients surviving more than three years. Recurrence (RGBM) is nearly universal, and further decrease...

Full description

Bibliographic Details
Main Authors: Rulseh Aaron, Keller Jiří, Klener Jan, Šroubek Jan, Dbalý Vladimír, Syrůček Martin, Tovaryš František, Vymazal Josef
Format: Article
Language:English
Published: BMC 2012-10-01
Series:World Journal of Surgical Oncology
Subjects:
Glioblastoma multiforme
Recurrent glioblastoma multiforme
Tumor-treating fields
Long-term survival
Online Access:http://www.wjso.com/content/10/1/220

Internet

http://www.wjso.com/content/10/1/220

Similar Items